Q2 2023 Holdings
Filed 2023-08-14 | 99 holdings | $679.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anaptysbio Inc(ANAB) | COM | 032724106 | $39.7M | 1,950,609 | 5.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $32.1M | 1,779,158 | 4.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $29.4M | 1,137,107 | 4.3% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $24.5M | 1,300,000 | 3.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $24.3M | 405,600 | 3.6% |
| Bluebird BIO Inc | COM | 09609G100 | $24.3M | 7,382,827 | 3.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $23.9M | 2,651,393 | 3.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $23.0M | 320,000 | 3.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $22.5M | 3,097,399 | 3.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $19.0M | 300,000 | 2.8% |
| New York Cmnty Bancorp Inc(NYCBEUR) | COM | 649445103 | $18.1M | 1,606,600 | 2.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $17.2M | 2,450,000 | 2.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.5M | 692,925 | 2.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $15.2M | 85,000 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $15.0M | 300,000 | 2.2% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $14.1M | 30,000 | 2.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $12.9M | 2,900,000 | 1.9% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $12.2M | 170,000 | 1.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.4M | 6,600,000 | 1.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $11.3M | 3,026,455 | 1.7% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $11.0M | 3,674,076 | 1.6% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $9.7M | 2,750,000 | 1.4% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $9.5M | 271,200 | 1.4% |
| Zymeworks del Inc(ZYME) | COM | 98985Y108 | $9.5M | 1,100,000 | 1.4% |
| Moderna Inc(MRNA) | COM | 60770K107 | $9.3M | 76,700 | 1.4% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $8.7M | 80,000 | 1.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $8.7M | 1,800,000 | 1.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $8.5M | 1,140,000 | 1.2% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $8.4M | 7,100,000 | 1.2% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $8.4M | 600,000 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $8.2M | 200,000 | 1.2% |
| Elevation Oncology Inc | COM | 28623U101 | $6.1M | 4,000,000 | 0.9% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $6.1M | 16,000 | 0.9% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $6.0M | 2,479,552 | 0.9% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $5.4M | 3,613,280 | 0.8% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $5.4M | 2,085,625 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $4.8M | 450,000 | 0.7% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $4.6M | 1,260,000 | 0.7% |
| Citigroup Inc(C) | COM NEW | 172967424 | $4.6M | 100,000 | 0.7% |
| Magenta Therapeutics Inc | COM | 55910K108 | $4.6M | 6,060,000 | 0.7% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $4.6M | 1,787,775 | 0.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $4.5M | 4,887,238 | 0.7% |
| Rain Oncology Inc | COM | 75082Q105 | $4.5M | 3,740,341 | 0.7% |
| Genfit S A | ADS | 372279109 | $4.4M | 1,234,436 | 0.6% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $4.3M | 3,333,803 | 0.6% |
| Enzo Biochem Inc(ENZB) | COM | 294100102 | $4.2M | 2,300,000 | 0.6% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $4.2M | 100,000 | 0.6% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $4.1M | 1,128,068 | 0.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $3.9M | 300,000 | 0.6% |
| Veritex Hldgs Inc(VBTX) | COM | 923451108 | $3.8M | 210,000 | 0.6% |